A new scientific engagement service has been introduced by WE Communications

A brand-new scientific engagement and medical education offering has been created by WE Communications, who have obtained both Ben Fisher and Terry Bradley to manage it.

The UK based pair will be the directors at WE Communications, with the responsibility of making new business for the service, as well as supporting the agency’s clients at a national, EMEA and worldwide level.

Fisher has worked with agencies including, Omnicom and WPP, and has twenty years of experience within the healthcare communications sector. Meanwhile, Bradley has over thirty years of experience within the healthcare communications sector, where he has worked across life science journal and clinical review.

Fisher stated: “Scientific engagement enables our clients to tell the human story behind the data. Behavioural science will be at the heart of everything we do and all our programmes will be designed with the purpose of illustrating the positive impact of our clients’ innovations in this unprecedented time.”

Bradley stated: “Now more than ever, pharma companies need help understanding the role technology can play in their new normal and how to effectively deploy it to increase audience engagement and understanding. I look forward to partnering with clients to navigate this rapidly changing environment, extending the agency’s already established data-driven, creative communications offer to scientific engagement and medical education.”

Head of health and UK deputy managing director, WE Communications, Catherine Devaney, stated: “COVID-19 has triggered a vital revolution in the way pharmaceutical companies need to engage with their stakeholders. The pandemic has been a catalyst for speeding up the use of technology by pharma to quickly reach and educate audiences, especially given the demand for rapid progress in resolving this health crisis.”